Appraise the importance of innate immunity
Understand the process of inflammation
Recognize the functions of inflammatory mediators
Compare acute and chronic inflammation
innate immunity involves non-specific and broadly specific control
Cells involved
Neutrophil & natural killer cell: primarily phagocytes bacteria and other pathogens
Macrophage
bridging innate and adaptive by activating T cells
phagocyte dead cells and bacteria
secrete cytokines
Dendritic cell
antigen presenting cells
secrete cytokines
bridging innate and adaptive by activating T cells
Exogenous causes
physical injury: trauma, burn
chemical agents: toxic gases, acids…
biological agents: bacteria, viruses, parasites
Endogenous causes
immune reactions (hypersensitivity)
circulaton disorders (thrombosis)
metabolic products deposals (uric acids)
metabolic syndrome
arthritis
alzheimer’s disease
asthma
ulcerative colitis and inflammatory Bowel disease
colon, breasy and lung cancers
eye disorders
cardiovascular disease
gingivitis
Types
infarction
bacterial infection
toxin
trauma
result: mast cell secrete histamine
vasodilation → increase blood flow
stimulated by cytokines
plasma fluid: fibrin and antibody → tissue edema
lymphoctes and bacteria → lymphatic system → adaptive immunity
margination: getting close to blood vessel wall
rolling
binding of selectin ligand (on neutrophil) to E- or P-selectin (on endothelium)
binding of chemokine receptor (on neutrophil) to chemokine (IL-1 secreted by macrophage) presented by proteoglycan (on endothelium) → activate neutrophil
adhesion: binding of β2 integrin (on neutrophil) to ICAM-1
transmigrate from blood vessel to tissue
cytokines produced by Langerhan cells and macrophage attract neutrophils to site of infection
initial: activating neutrophils → kill microbes by short-lived
later stage: activating monocytes (multi-potential)
IFN-γ → stronger killing ability
IL-4 → macrophages: tissue repair and barrier immunity
IL-10 → clean up cell debris during resolution
engulf pathogens or apoptotic cells
form phagosome
fuse with lysosome → phagolysosome
digested by lysozyme and released as exocytic vesicles
process
granulocytes secrete lipoxin → initiate termination
secrete resolvins and protectins (anti-inflammatory) → stop neutrophil recruitment
macrophage engilf apoptotic neutrophils → release TGF-β
decrease pro-inflammatory cytokines (leukotrienes) & increase anti-inflammatory cytokines (IL1 receptor antagonist)
increase IL-4 and IL-10
macrophage leaves and end of inflammation
outcomes
resolution
inflammed tissue back to normal status
stop vasodilation, cytokine production and leukocyte infiltration
fibrosis
inflamed tissue is damaged and cannot regenerate
fibrous scarring by collagen → functional repair
pus/abscess formation
dead leukocytes and bacteria and debris from destroyed cells
chronic inflammation
due to persistant stimuli
dominating presence of macrophages: release ROS → tissue destruction
produced by mast cells and basophils
increase permeability of blood capillaries via H1 receptors
drug: histamine antagonist → block H1 receptor to treat allergy or runny nose
produced by tissue macrophages, monocytes, mast cells and endothelial cells
trigger fever
induce IL-6 (stimulate acute-phase proteins) , IL-8 and IFN-γ (induce prostaglandins)
eicosanoid inflammatory mediator
induces vasodilation, capilary permeability, pain and fever
PGE1 and PGE2 → inflammation & potentiate histamine’s effect
production determined by arachidonic acid, COX1 and COX2
related drug
NSAIDs: blck COX1 and COX2
corticosteroids: inhibit phospholipase A2 release
eicosanoid inflammatory mediator
produced by enzyme 5-lipoxygenase
similar fucntion with PG
induce chemotaxis and extra-vascularisation of neutrophils, eosinophils and monocytes
related drug: leukotriene receptor antagonist → treat asthma
induces platelet aggregation
activate neutrophils
strong chemoattractant of eosinophil
→ extra-vascularisation of plasma proteins → edema
produced by kinin system
increase vascular permeability
smooth muscle contraction
inflammation
activate fibrinolytic system: degrade fibrin
fibrin undergo fibrinolysis → fibrinopeptide → increase vascular permeability and attract leukocytes
produced by coagulation system
convert soluble fibrinogen → insoluble fibrin
produced by complement system
C3
C3a: induces histamine release by mast cell
C3b: opsonisation
C5
C5a: induces histamine release by mast cell
C5b: strong chemoattractant
MAC (membrane attack complex)
C5b + C6 + C7 + C8 + polymeric C9
insert into bacterial cell wall → lysis
inducing agent
acute
pathogen
injured tissues
allergens
chronic
non-degradable pathogens
persistant foreign body
autoinmmune response
cells involved
acute
neutrophils
monocytes
macrophage
basophils
eosinophils
mast cells
chronic
monocytes
macrophage
lymphocytes
plasma cells
fibroblast
process
acute
vacular changes
neutrophils recruitment
chronic
angiogenesis
mononuclear cell infiltration
outcomes
acute
resolution
abcess formation
chronic inflammation
chronic
tissue destruction
fibrosis
necrosis
whole-body inflammation caused by infection
symptoms
high fever
increased heart rate and breathing rate
bacteria septicemia (sepsis syndrome by bacterial infection)
activate monocytes → TNFα and IL-1 release → inflammation
shock from loss of blood pressure due to vasodilation and leakge of fluid into tissue
enhanced coagulation
results: multi-organ failure and death